Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 15Phase 1/2 12Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Squamous Cell Carcinoma of Head and Neck 6Head and Neck Neoplasms 6Lung Neoplasms 4Neoplasm Metastasis 3Melanoma 3Skin Neoplasms 2Recurrence 2Cholangiocarcinoma 2Advanced Solid Tumor 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Squamous NSCLC 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Nonsquamous Non-small Cell Lung Cancer 1Neoplasms, Squamous Cell 1Neoplasms 1Mouth Neoplasms 1Mesothelioma 1Liver Neoplasms 1Laryngeal Neoplasms 1Laryngeal Diseases 1Klatskin Tumor 1Kidney Neoplasms 1Hypopharyngeal Neoplasms 1Hodgkin Disease 1Hepatoblastoma 1

Interventions

Temozolomide 3Gemcitabine 3Etoposide 3pembrolizumab 2Rituximab 2Lomustine 2Haloperidol 2Dexamethasone 2Cyclosporine 2vocimagene amiretrorepvec 1trofosfamide 1tinostamustine 1selinexor 1ruxolitinib 1regorafenib 1peginterferon alfa-2b 1osimertinib 1menatetrenone 1interferon gamma-1b 1interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1imetelstat 1glumetinib 1fludarabine 1etoposide phosphate 1eculizumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1carbon-11 acetate 1blinatumomab 1auricularum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Recurrence × pembrolizumab × Clear all
NCT04534205 2026-05-22

AHEAD-MERIT

BioNTech SE

Phase 2/3 Recruiting
350 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT05595447 2025-03-12

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

Hospital Regional de Alta Especialidad del Bajio

Phase 2/3 Recruiting
20 enrolled
Lymphoid

Hodgkin Disease, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡